Your Search Results

      • Trusted Partner
        2021

        Psychotropic Drugs in General Practice

        How to recognise, understand and treat patients successfully

        by PD Dr. Daniel Schüpbach and Dr. Otto Dietmaier

        The purpose of this book is to support general practitioners in finding the optimum, guideline-compliant therapy for their patients. The focus is on the clinical pictures of depression, psychosis as well as anxiety and sleep disorders and the handling of psychiatric emergencies. The reader will learn everything about the epidemiology, aetiology, diagnosis and medical treatment of these diseases, about switching therapy and about treatment in pregnancy and lactation. All the available psychotropic drugs and their pharmacological properties are described in detail – including key specific features of active substances and drug safety aspects. The table of substances in the appendix provides a clear summary of the information and simplifies the choice of the appropriate drug. The extras: - 13 factsheets with concise, summarised information to cope with tricky situations in the practice - The authors take the current treatment guidelines from Germany, Austria and Switzerland into account and name examples of proprietary medicinal products in the three countries.

      • Trusted Partner
        Humanities & Social Sciences

        Clinical Handbook of Psychotropic Drugs

        by Ric M. Procyshyn / Kalyna Z. Bezchlibnyk-Butler / J. Joel Jeffries (Eds.)

        The “Clinical Handbook of Psychotropic Drugs” has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.• Independent, unbiased, up-to-date• Packed with unique, easy-to-read comparison charts andtables (dosages, side effects, pharmacokinetics, interactions…)for a quick overview of treatment options• Succinct, bulleted information on all classes of medication:on- and off-label indications, (US FDA, Health Canada),recommended dosages, US and Canadian trade names, sideeffects, interactions, pharmacodynamics, precautions inthe young, the elderly, and pregnancy, nursing implications,and much more – all you need to know for each class of drug• Potential interactions and side effects summarized incomparison charts• With instantly recognizable icons and in full color throughout,allowing you to find at a glance all the information you seek• Clearly written patient information sheets available fordownload as printable PDF files This book is a must for everyone who needs an up-to-date, easyto- use, comprehensive summary of all the most relevant information about psychotropic drugs. Tables, graphs, and overviews make this handbook a practical tool for professionals. For:• psychiatrists und psychologists• physicians and pharmacists• nurses, and other mental health

      • Trusted Partner
        2021

        Psychopharmacology and Psychopharmacotherapy.A Concise Guide

        Training curriculum for medical specialists in psychiatry and psychotherapy

        by Edited by Prof. Dr. Dipl.-Psych. Gerd Laux and Prof. Dr. Walter E. Müller

        Psychotropic drugs have established their place in mental illnesses and form an important element of treatment. This textbook guides the selection of pharmacotherapy for a variety of psychological disorders such as depression, schizophrenia or dementia. The reader will learn, - How to use the various drugs in a targeted manner - The mechanisms of action on which they are based - Why side effects occur and how they can be dealt with. This book corresponds to the curriculum for the training of medical specialists in psychiatry and psychotherapy. It is an indispensable aid to anyone who uses psychotropic drugs!

      • Trusted Partner

        HOW TO CHANGE YOUR BODY

        The Science of Interoception and Healing Through Connection to Yourself & Others

        by Saga Briggs

        Drawing from the latest research on interoception— which examines how our senseof self arises from subjective appraisal of bodily signals and how those appraisal habits develop in childhood—the book argues for a reframing of depression, anxiety, PTSD, and other “mental health” issues as social-emotional illnesses rooted in the body. Saga Briggs harnesses psychedelic science to show how interoception can be altered by psychoactive substances, providing an additional framework for understanding their therapeutic benefits.

      • Trusted Partner

        The Secret Chief Revealed

        Conversations with Leo Zeff, Pioneer in the Underground Psychedelic Therapy Movement

        by Myron J. Stolaroff

        Leo Zeff (1912 – 1988) was a pioneering psychedelic therapist and researcher focused on LSD, MDMA and other psychoactive drugs. He conducted much of his work and practice underground after psychedelics were declared illegal in the 1960s. By the time he turned 70, Zeff was single-handedly responsible for the introduction of psychedelic compounds in use globally among nearly 4,000 individual therapists/practitioners. The Secret Chief Revealed is written as a transcription of an interview conducted in the 1980s with Zeff about his research, studies, and practice with psychedelicassisted therapy. The revised 2nd edition maintains much of the 2nd edition release, including thoughtful contributions on Zeff’s lifework/research from other leaders in the psychedelic movement including Albert Hofmann, discoverer of LSD, psychedelic researcher and author, Stanislav Grov, a founder of transpersonal psychology, and Ann & Alexander Shulgin, renowned psychedelic researchers and authors, who also mention Zeff in Pihkal: A Chemical Love Story.

      • Trusted Partner
        2024

        Intoxicating Drugs

        Known and new psychoactive substances

        by Prof. Dr. Niels Eckstein

        Intoxicating? Intoxicating drugs are as old as mankind itself. Whether herbal or produced synthetically in a laboratory, their variety is almost limitless. And every year, more substances are added to the list. Niels Eckstein, who is a Professor of Drug Regulatory Affairs and Pharmacology and a long-standing expert in the narcotics scene, explores the abysses of the darknet and dealer hell, provides insider information, conducts interviews with dealers and producers, and offers profound insights into the bizarre, parallel world of intoxicating substances. At the same time, the author takes a thorough look at the chemistry of the different substance classes and the neurobiological basis of addiction. He also covers production and assesses the danger and addiction potential of designer drugs, BTM, NPS, medicinal drugs and doping substances. This book outlines the political and sociopolitical dimensions of the use of psychoactive substances, classifies them legally, describes risks, approaches, and help strategies, highlights routes out of drug problems and alternatives to drug prohibition, and comments on the opioid crisis in the United States and the „war on drugs.“ “I don‘t care how it‘s regulated: if he wants it and can pay for it, he gets it. If I get caught, I‘ll go to jail for a few years, whether it‘s for a kilo of coke, meph or testo, it doesn‘t matter.“ – In an interview with a dealer

      • Trusted Partner
        Medicine
        July 2024

        On trial

        Testing new drugs in psychiatry, 1940–1980

        by Marietta Meier, Magaly Tornay, Mario König

        The heroic story of the invention of antidepressants is a key part of the psychopharmaceutical turn. On Trial revolves around one of its pioneers, psychiatrist Roland Kuhn, who practiced in Münsterlingen, a state-run psychiatric hospital in Switzerland. Kuhn became famous for the 'discovery' of the first antidepressant, Tofranil, and more recently notorious for his numerous trials on often unsuspecting patients. Largely based on the extensive and previously inaccessible sources of Kuhn's private archive, the book delves into the early days of industry-sponsored clinical research in psychiatry. It examines how the clinic, patients, doctors, nursing staff, corporations, and authorities interacted in the trials. Conducted from the 1940s to 1980s, the Münsterlingen drug trials are historicised and situated in the period's evolving landscape of experimentation.

      • Trusted Partner
        April 2022

        Fritz, the Gorilla

        Biography of a Fascinating Ape

        by Jenny von Sperber

        When Jenny von Sperber first met Fritz, the gorilla didn’t let her out of his sight. He was already over 50 years old then, but he was still extremely charismatic. One thing matters for the journalist: she wants to find out everything about Fritz’s life. Born in 1963, he was captured in the wild and came from Cameroon to Germany in 1966. At that time, apes were still regarded as a curiosity in zoos. When a ban was declared on the wild gorilla trade, Fritz was already a father of many youngsters. This fascinating gorilla-family saga not only recounts the eventful life of Fritz, but also shows the development in European zoos in handling wild animals. Nowadays, things have certainly improved. But there are still questions, for example, what does it do to us when we marvel at our closest relatives behind glass? And is it even still current to confine apes ... was it ever?

      • Trusted Partner

        NATURE OF DRUGS

        A Course on Pharmacology, Pharmacokinetics, Societal Responses and Social Impact Vol 1

        by Alexander Shulgin

        The Nature of Drugs is the story of humanity’s relationship with psychoactive substances from the perspective of a master psychopharmacologist. Derived from a lecture series by “Sasha” Shulgin at SFSU on the origins of drugs, how they work, how they are processed in the body, and how they affect our society. *Release Date Spring 2021

      • Social groups
        January 1994

        Understanding and Preventing Violence, Volume 3

        Social Influences

        by Albert J. Reiss, Jr. and Jeffrey A. Roth, Editors, Panel on the Understanding and Control of Violent Behavior, National Research Council

        This volume examines social influences on violent events and violent behavior, particularly concentrating on how the risks of violent criminal offending and victimization are influenced by communities, social situations, and individuals; the role of spouses and intimates; the differences in violence levels between males and females; and the roles of psychoactive substances in violent events.

      • Trusted Partner
        Humanities & Social Sciences

        CHANGING OUR MINDS

        Psychedelic Sacraments and the New Psychotherapy

        by Don Lattin

        A look at the recent history and credible prospects for using MDMA, psilocybin, and ayahuasca to treat mood disorders and promote spiritual well-being. Changing Our Minds is an experiential tour through a social, spiritual and scientific revolution that is redefining our culture’s often-confusing relationship with psychoactive substances.Veteran journalist Don Lattin chronicles the inspiring stories of pioneering neuroscientists, psychotherapists, spiritual guides and ordinary people seeking to live healthier lives by combining psychedelic drugs, psychotherapy, and the wise use of ancient plant medicines. In ground-breaking clinical trials, specially trained therapists employ Ecstasy (MDMA) to help U.S. veterans struggling with the psychological aftermath of war.Other psychiatrists in government-approved research offer psilocybin to alcoholics trying to get sober and cancer patients struggling with the existential distress of a life-threatening illness.Meanwhile, new imaging technology has enabled neuroscientists to map the psychedelic brain in real time, deepening our understanding of human consciousness. the essential primer for understanding and navigating this new consciousness-raising territory.

      • Humanities & Social Sciences
        July 2017

        Disrupt The Process of Drug Addiction

        by Fredrick Norfleet

        Reading "DISRUPT: THE PROCESS OF DRUG ADDICTION", will transform your life! Drug addiction is a process, consequently, when the process of addiction is disrupted benefits flourish. Moreover, just by opening the pages of this book, 'Disrupt: The Process of Drug Addiction' you have taken the first footstep to shifting your life domain. You should be proud of yourself for becoming an instrument to, "Disrupt: The Process of Drug Addiction".

      • Health & Personal Development
        May 2016

        The Drug Conversation

        How to talk to your child about drugs

        by Owen Bowden-Jones

        The Drug Conversation is a guide for parents about how to raise the thorny issue of drugs with their children. It will help you begin a useful conversation about drugs with your child. The book provides information on the different types of psychoactive drugs available, their attractions and harms, how they work in the brain, and who uses them and why. It covers issues such as how to detect drug use, drug testing, synthetic drugs (‘legal highs’), accessing help, effective treatments and what to expect from professional medical services. The Drug Conversation also gives practical advice on how to prepare for and have a conversation about drugs with your child – including examples of actual conversations between parents and children. Case studies from the author’s own clinical practice are used to illustrate the main points. All parents will need this book at some stage. It will help you to feel properly informed about drugs, more confident in talking to your child, more able to keep drug-related problems from developing and better equipped to tackle problems if they do arise

      • Diseases & disorders
        June 2004

        New Treatments for Addiction

        Behavioral, Ethical, Legal, and Social Questions

        by Henrick J. Harwood and Tracy G. Myers, Editors, Committee on Immunotherapies and Sustained-Release Formulations for Treating Drug Addiction, National Research Council

        New and improved therapies to treat and protect against drug dependence and abuse are urgently needed. In the United States alone about 50 million people regularly smoke tobacco and another 5 million are addicted to other drugs. In a given year, millions of these individuals attemptâ€"with or without medical assistanceâ€"to quit using drugs, though relapse remains the norm. Furthermore, each year several million teenagers start smoking and nearly as many take illicit drugs for the first time. Research is advancing on promising new means of treating drug addiction using immunotherapies and sustained-release (depot) medications. The aim of this research is to develop medications that can block or significantly attenuate the psychoactive effects of such drugs as cocaine, nicotine, heroin, phencyclidine, and methamphetamine for weeks or months at a time. This represents a fundamentally new therapeutic approach that shows promise for treating drug addiction problems that were difficult to treat in the past. Despite their potential benefits, however, several characteristics of these new methods pose distinct behavioral, ethical, legal, and social challenges that require careful scrutiny. Such issues can be considered unique aspects of safety and efficacy that are fundamentally related to the distinct nature and properties of these new types of medications.

      • Health & Personal Development
        2014

        RESOLVING PROBLEM PATTERNS

        with Clean Language and Autogenic Metaphor

        by Philip Harland

        How can problem patterns be discerned, decoded and the information within them released? This guide has five parts: ‘What is as Pattern?’ ‘How Can Patterns be Discerned?’ ‘How Can Problem Patterns be Decoded?’ ‘How Can the Information Within be Released?’ and ‘Then What Happens: the Nature of Change’. At a time when psychoactive drugs are being prescribed more widely than at any time in history, it is more important than ever to educate ourselves about the alternatives. The drug-free resolution of problem patterns of behavior, feeling or belief is as important for health professionals to be able to facilitate as it is for their clients and patients to achieve. This guide has a bias towards the talking therapies – and in particular the radical new art of Clean Language – but its precepts and procedures are applicable to any area of human enquiry. New, more productive, patterns of behaviour, feeling and belief emerge through CleanLanguage modelling as the client identifies component parts of their perceptions, develops these in form, space, or time; elucidates key relationships between them; discerns patterns across the relationships and translates these patterns to their everyday lives. As a result it is the client, not the facilitator, who determines the significance of their perceptions. And as the system learns about its own organization, a context for self-generated change is created and it is the client, not the facilitator, who determines what needs to happen for the system to evolve.  Philip Harland is a Clean Language psychotherapist and author of ‘Trust Me, I’m the Patient: Clean Language, Metaphor and the New Psychology of Change’; ‘The Power of Six: a Six Part Guide to Self Knowledge’; ‘Possession and Desire: understanding and working with addiction, compulsion and dependency’; and ‘How the Brain Feels: working with emotion and cognition’; all published by Wayfinder Press, London England. For more on these books see Amazon and www.wayfinderpress.co.uk

      • October 2021

        Pediatric Psychopharmacology for Primary Care

        by Editor: Mark A. Riddle, MD

        The revised and updated third edition of this best-selling resource provides primary care physicians with practice-tested, condition-specific treatment recommendations for various mental and psychiatric disorders or behavioral problems in children and adolescents.   Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications. Ease medication decision-making with a clear, straightforward methodology based on current research and clinical experience. This simple, systematic approach defines discrete levels of psychotropics and describes their group-specific roles and responsibilities in accordance with American Academy of Pediatrics policies. The accompanying digital tool offers instant access to authoritative answers on specific conditions and psychotropic medications.

      • Medicine

        International Clinical Psychopharmacology

        An International Journal for Collaboration Between Research and Clinical Practice

        by Edited by Stuart A Montgomery

        Bimonthly - 2013 Volume(s) - 26 www.intclinpsychopharm.com International Clinical Psychopharmacology continues to maintain its high standing in publication of research and clinical practice within the field of psychopharmacology. This respected journal is largely concerned with psychotropic drugs, covering phase I-IV studies, clinical studies, side-effects and epidemiology. Papers deal with studies on both healthy volunteers and patients. Regular volume indexes make the journal an invaluable reference in the field.

      • Medicine

        Journal of Clinical Psychopharmacology

        by Edited by Richard I Shader , David J Greenblatt MD

        Bimonthly - 2013 Volume(s) - 31 www.psychopharmacology.com This leading publication in psychopharmacology offers a wide range of articles that report on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, medico-legal issues, and psychiatric effects of non-psychiatric drugs. The Journal keeps psychiatrists and psychiatric residents up-to-date on the latest clinical developments in the psychotropics, presenting the extensive coverage needed to keep up with every development in this fast-growing field.

      Subscribe to our

      newsletter